GDMT Across the Span of Kidney Disease
Internal Medicine Resident Yale New Haven-Bridgeport Hospital Bridgeport, CT Cardiology Fellow Yale School of Medicine New Haven, CT Click this button to try the live prototype at GDMT.org Guideline-directed medical therapies (GDMT) are under-prescribed in heart failure with reduced ejection fraction (HFrEF) patients who have concomitant chronic kidney disease (CKD) or end-stage kidney disease (ESKD) in both the inpatient and outpatient settings 1,2, despite the established benefit of GDMT in reducing
